EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2
EMA has received an application for conditional marketing authorisation (CMA) for BNT162b2, a COVID?19 mRNA...
Biogen partners with Sage Therapeutics on depression, movement disorder drugs
Biogen entered into an agreement to jointly develop and commercialise Sage Therapeutics' zuranolone for major...
AstraZeneca Says Forxiga Approved In Japan For Heart Failure
AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chronic...
Lonza invests to expand manufacturing capabilities at Oregon site
Lonza AG has announced a significant investment to expand its particle engineering and drug product...
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a...
Moderna Announces Amendment to Current Supply Agreement with UK Government for an Additional 2...
Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create...
Wasdell Group strengthens PPFL business with ISO 13485 for medical devices
The Wasdell Group, a leading outsourcing partner to companies in the pharmaceutical and biotech sector,...
Saudi Pharma in talks with Germanys CureVac for coronavirus shot
Saudi Pharmaceutical Industries and Medical Appliances Corp. have signed a non-binding memorandum of understanding with...
Recipharm announces signature of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19...
Recipharm, a leading contract development and manufacturing organisation (CDMO) announces that it has signed a...
Patent Protection Lift-off For COVID-19 Vaccines; Not a Bright Choice
The world of Pharmaceuticals is caught in the web of who brings out the vaccine...
